Axogen Inc. (NASDAQ: AXGN) on Tuesday, soared 0.99% from the previous trading day, before settling in for the closing price of $13.15. Within the past 52 weeks, AXGN’s price has moved between $3.45 and $15.23.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 13.87% over the past five years. The company achieved an average annual earnings per share of 89.22%. With a float of $41.33 million, this company’s outstanding shares have now reached $43.12 million.
Let’s look at the performance matrix of the company that is accounted for 428 employees. In terms of profitability, gross margin is 77.79%, operating margin of -7.04%, and the pretax margin is -9.53%.
Axogen Inc. (AXGN) Insider Updates
Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Axogen Inc. is 5.71%, while institutional ownership is 80.54%. The most recent insider transaction that took place on Sep 05 ’24, was worth 1,950,000. Before that another transaction happened on Aug 21 ’24, when Company’s Officer proposed sale 28,003 for $12.42, making the entire transaction worth $347,810.
Axogen Inc. (AXGN) Performance Highlights and Predictions
As on 6/30/2024, Multinational firm has announced its last quarter scores, in which it reported 0.01 earnings per share (EPS) for the period topping the consensus outlook (set at -0.06) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.01 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 89.22% per share during the next fiscal year.
Axogen Inc. (NASDAQ: AXGN) Trading Performance Indicators
Axogen Inc. (AXGN) is currently performing well based on its current performance indicators. A quick ratio of 2.32 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.36.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.38, a number that is poised to hit 0.01 in the next quarter and is forecasted to reach 0.17 in one year’s time.
Technical Analysis of Axogen Inc. (AXGN)
Axogen Inc. (NASDAQ: AXGN) saw its 5-day average volume 0.45 million, a positive change from its year-to-date volume of 0.4 million. As of the previous 9 days, the stock’s Stochastic %D was 11.70%. Additionally, its Average True Range was 0.60.
During the past 100 days, Axogen Inc.’s (AXGN) raw stochastic average was set at 77.48%, which indicates a significant increase from 18.41% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 58.56% in the past 14 days, which was lower than the 68.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.35, while its 200-day Moving Average is $9.38. Nevertheless, the first resistance level for the watch stands at $13.40 in the near term. At $13.52, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.69. If the price goes on to break the first support level at $13.11, it is likely to go to the next support level at $12.94. Assuming the price breaks the second support level, the third support level stands at $12.82.
Axogen Inc. (NASDAQ: AXGN) Key Stats
Market capitalization of the company is 582.06 million based on 43,705K outstanding shares. Right now, sales total 159,010 K and income totals -21,720 K. The company made 47,910 K in profit during its latest quarter, and -1,920 K in sales during its previous quarter.
